As federal policymakers weigh potential changes to how biomedical research is funded and regulated in the United States, a ...

Bio-inspired medical devices can gather more data than ever before, and HPC/quantum will massively speed up discovery rates; consumer self-testing will be slower.

Tom Gardner outlines two selective AI opportunities and a disciplined portfolio framework for the next three to five years.